About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Chicago | 101 Studies

Clinical Trials Brain CancerChicago

Brain Cancer Clinical Trials in Chicago

Find 101 clinical trials for brain cancer near Chicago, Illinois. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 101 trials

CompletedSafety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9Recurrent glioblastoma (GBM) is a disease with high unmet clinical need. The standard of care for patients with GBM includes surgery, radiotherapy and chemotherapy.NCT03744026·Chicago, Illinois and 5 others CompletedSorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent GlioblastomaThis phase I/II trial studies the side effects and best dose of temsirolimus when given together with sorafenib tosylate and to see how well they work in treating patients with…NCT00329719·Anchorage, Alaska and 189 others

Brain Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingStudy of Olutasidenib and Temozolomide in HGGThe goal of this study is to determine the efficacy of the study drug olutasidenib to treat newly diagnosed pediatric and young adult patients with a high-grade glioma (HGG)…NCT06161974·Aurora, Colorado and 19 others

CompletedImetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaRATIONALE: Imetelstat sodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT01273090·Birmingham, Alabama and 22 others

UnknownSafety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant GliomaThe purpose of this study is to evaluate the safety and biologically active dose of TM-601 in adult patients with recurrent malignant glioma.NCT00591058·Birmingham, Alabama and 6 others

CompletedNeural Stem Cell Based Virotherapy of Newly Diagnosed Malignant GliomaMalignant gliomas have a very poor prognosis with median survival measured in months rather than years. It is a disease in great need of novel therapeutic approaches.NCT03072134·Duarte, California and 1 other

CompletedANG1005 in Patients With Recurrent High-Grade GliomaThis is a Phase 2 study to see if an investigational drug, ANG1005, can shrink tumor cells in patients with high-grade glioma.NCT01967810·La Jolla, California and 11 others

RecruitingTargeted Pediatric High-Grade Glioma TherapyThe goal of this study is to perform genetic sequencing on brain tumors from children, adolescents, and young adult patients who have been newly diagnosed with a high-grade glioma.NCT05839379·Aurora, Colorado and 21 others

CompletedRebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaPhase II trial to study the effectiveness of rebeccamycin analogue in treating children who have solid tumors or non-Hodgkin's lymphoma.NCT00006102·Birmingham, Alabama and 225 others

CompletedA Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive GlioblastomaThe purpose of this research study is to find out whether adding an experimental vaccine called rindopepimut (also known as CDX-110) to the commonly used drug bevacizumab can…NCT01498328·Birmingham, Alabama and 44 others

CompletedValproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS TumorsRATIONALE: Drugs used in chemotherapy, such as valproic acid, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00107458·Orange, California and 16 others

CompletedBevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma MultiformeThis partially randomized phase I/II trial studies the side effects and the best dose of anti-endoglin monoclonal antibody TRC105 when given together with bevacizumab and to see…NCT01648348·Little Rock, Arkansas and 307 others

CompletedStudy of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain TumorsIn this study, investigators will conduct a phase I/II trial in recurrent (temozolomide resistant) glioma patients.NCT02052648·Castro Valley, California and 16 others

CompletedTesting Ramipril to Prevent Memory Loss in People With GlioblastomaThis study is to determine if an oral drug called Ramipril can lower the chance of memory loss in patients with glioblastoma getting chemoradiation.NCT03475186·Anchorage, Alaska and 422 others

CompletedAdult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade GliomasThis study was conducted to evaluate the efficacy and safety of depatuxizumab mafodotin (ABT-414) alone or with temozolomide versus temozolomide or lomustine alone in adult…NCT02343406·Palo Alto, California and 101 others

TerminatedTesting Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain TumorsRecent advances in technology have allowed for the detection of cell-free DNA (cfDNA). cfDNA is tumor DNA that can be found in the fluid that surrounds the brain and spinal cord…NCT05934630·Los Angeles, California and 9 others

CompletedRadiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma MultiformeRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00099125·Phoenix, Arizona and 117 others

CompletedVNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain TumorsRATIONALE: Drugs used in chemotherapy, such as VNP40101M, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00098761·San Francisco, California and 9 others

CompletedStem Cell Transplant for High Risk Central Nervous System (CNS) TumorsThe primary goal of this study is to determine if a stem cell transplant in patients with newly diagnosed high risk CNS tumors (glioblastoma multiforme \[GBM\], high grade…NCT00179803·Chicago, Illinois

RecruitingTesting the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous TreatmentThis phase I/II trial tests the safety, side effects and best dose of selinexor given in combination with the usual chemotherapy (temozolomide) and compares the effect of this…NCT05432804·Phoenix, Arizona and 35 others

PreviousPage 3 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia